Clinical Trials Directory

Trials / Conditions / Advanced Gastroesophageal Junction Adenocarcinoma

Advanced Gastroesophageal Junction Adenocarcinoma

13 registered clinical trials studyying Advanced Gastroesophageal Junction Adenocarcinoma — 8 currently recruiting.

StatusTrialSponsorPhase
RecruitingTotal Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
NCT06028737
Ukrainian Society of Clinical OncologyPhase 2 / Phase 3
Not Yet RecruitingSHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcin
NCT06666166
Yunpeng LiuPhase 2
RecruitingAdding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
NCT06203600
National Cancer Institute (NCI)Phase 2 / Phase 3
RecruitingMulti-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gas
NCT06642857
Xiangdong Cheng—
RecruitingCPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Pati
NCT05733000
Northwestern UniversityPhase 2
RecruitingmFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastati
NCT05677490
Alliance for Clinical Trials in OncologyPhase 3
UnknownReal-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy
NCT05649163
Shen Lin—
RecruitingPembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adeno
NCT05041153
M.D. Anderson Cancer CenterEARLY_Phase 1
Active Not RecruitingTesting the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advance
NCT04391049
NRG OncologyPhase 1
Active Not RecruitingTesting the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or
NCT04535401
National Cancer Institute (NCI)Phase 1
RecruitingTesting the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tu
NCT04704661
National Cancer Institute (NCI)Phase 1
UnknownTislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC
NCT04890392
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 2
CompletedPembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma
NCT03395847
M.D. Anderson Cancer CenterEARLY_Phase 1